Entropy Neurodynamics Limited has released a press release.
Quarterly Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Entropy Neurodynamics Limited on 6ix
Story so far
Earlier from Entropy Neurodynamics
- September Quarterly Report and Appendix 4C
- Exopharm raises $10m in well supported Placement
- Appendix 4E and Annual Financial Report FY 2020
- June Quarterly Report and Appendix 4C
- Added IP empowers Exopharms engineered exosome pipeline
Later from Entropy Neurodynamics
- Response to ASX Price and Volume Query
- Appendix 4D and Half Year Financial Report
- Preclinical Data from Osteoarthritis Animal Study
- Positive PLEXOVAL II Phase 1 Clinical Trial Results
- Exopharm Receives Firm Commitments to Raise $12 million
Follow Entropy Neurodynamics into a list and get an email when it puts out news.
Follow Entropy Neurodynamics